| Filed On | Filing |
|---|---|
| 24 Jun 2022 |
8-K/A: Notice of Delisting or Failure to Satisfy a Listing Rule
The below sentence amends and restates the original first sentence under Item 3.01 in its entirety. |
| 22 Dec 2021 |
8-K/A: Other Events
The accompanying notes are an integral part of these condensed financial statements |
| 16 Nov 2021 |
8-K/A: Regulation FD Disclosure
On November 10, 2021, InMed Pharmaceuticals Inc. announced financial results for the first quarter of fiscal year 2022 which ended September 30, 2021. The below paragraphs restate the original paragraphs under the subtitle “INM-088 for t... |
Loading...